GUNA Biotherapeutics was founded in 1983 and based in Milan.
Guna S.p.a. is the leading Italian Company in the production and distribution of complementary, low-dose and biological medicine, with a domestic market share of 25% and a turnover of over 61 million Euro in 2017.
Guna products are distributed in over 30 Countries in the world. Over 70 products are FDA listed and regulated and sold in the US through the subsidiary Guna Inc., located in Pennsylvania.
